Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics Revenue 2010-2025 | UTHR

United Therapeutics annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • United Therapeutics revenue for the quarter ending March 31, 2025 was $0.794B, a 17.22% increase year-over-year.
  • United Therapeutics revenue for the twelve months ending March 31, 2025 was $2.994B, a 19.85% increase year-over-year.
  • United Therapeutics annual revenue for 2024 was $2.877B, a 23.63% increase from 2023.
  • United Therapeutics annual revenue for 2023 was $2.328B, a 20.2% increase from 2022.
  • United Therapeutics annual revenue for 2022 was $1.936B, a 14.88% increase from 2021.
  
United Therapeutics Annual Revenue
(Millions of US $)
2024 $2,877
2023 $2,328
2022 $1,936
2021 $1,686
2020 $1,483
2019 $1,449
2018 $1,628
2017 $1,725
2016 $1,599
2015 $1,466
2014 $1,289
2013 $1,117
2012 $916
2011 $743
2010 $593
2009 $359
United Therapeutics Quarterly Revenue
(Millions of US $)
2025-03-31 $794
2024-12-31 $736
2024-09-30 $749
2024-06-30 $715
2024-03-31 $678
2023-12-31 $615
2023-09-30 $609
2023-06-30 $597
2023-03-31 $507
2022-12-31 $492
2022-09-30 $516
2022-06-30 $467
2022-03-31 $462
2021-12-31 $415
2021-09-30 $445
2021-06-30 $447
2021-03-31 $379
2020-12-31 $385
2020-09-30 $380
2020-06-30 $362
2020-03-31 $356
2019-12-31 $311
2019-09-30 $402
2019-06-30 $374
2019-03-31 $363
2018-12-31 $381
2018-09-30 $413
2018-06-30 $445
2018-03-31 $389
2017-12-31 $465
2017-09-30 $446
2017-06-30 $445
2017-03-31 $371
2016-12-31 $409
2016-09-30 $408
2016-06-30 $413
2016-03-31 $369
2015-12-31 $405
2015-09-30 $386
2015-06-30 $347
2015-03-31 $328
2014-12-31 $346
2014-09-30 $330
2014-06-30 $323
2014-03-31 $289
2013-12-31 $289
2013-09-30 $302
2013-06-30 $281
2013-03-31 $245
2012-12-31 $244
2012-09-30 $242
2012-06-30 $226
2012-03-31 $204
2011-12-31 $195
2011-09-30 $202
2011-06-30 $184
2011-03-31 $163
2010-12-31 $161
2010-09-30 $169
2010-06-30 $135
2010-03-31 $129
2009-12-31 $98
2009-09-30 $97
2009-06-30 $84
2009-03-31 $80
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.421B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.152B 31.57
Zoetis (ZTS) United States $75.067B 28.01
Takeda Pharmaceutical (TAK) Japan $47.697B 9.49
Daiichi Sankyo, - (DSNKY) Japan $46.849B 23.83
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.005B 12.46
Summit Therapeutics (SMMT) United States $14.653B 0.00
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $12.332B 42.24
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $10.039B 0.00
Corcept Therapeutics (CORT) United States $7.318B 59.49
Stevanato Group S.p.A (STVN) Italy $7.038B 43.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.086B 0.00
Grifols, S.A (GRFS) Spain $5.995B 0.00
Ionis Pharmaceuticals (IONS) United States $5.609B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.791B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.093B 10.84
Crinetics Pharmaceuticals (CRNX) United States $3.026B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
BioCryst Pharmaceuticals (BCRX) United States $2.298B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.247B 12.15
NewAmsterdam Pharma (NAMS) Netherlands $2.190B 0.00
Indivior (INDV) United States $1.874B 7.95
Recursion Pharmaceuticals (RXRX) United States $1.858B 0.00
Dyne Therapeutics (DYN) United States $1.590B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.584B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.348B 0.00
Guardian Pharmacy Services (GRDN) United States $1.324B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Harrow (HROW) United States $1.054B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Akebia Therapeutics (AKBA) United States $0.969B 0.00
Collegium Pharmaceutical (COLL) United States $0.948B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.871B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.686B 0.00
Xencor (XNCR) United States $0.649B 0.00
Liminatus Pharma (LIMN) United States $0.640B 0.00
AleAnna (ANNA) United States $0.608B 0.00
Elite Pharmaceuticals (ELTP) United States $0.595B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.541B 11.77
Theravance Biopharma (TBPH) United States $0.539B 0.00
Bioventus (BVS) United States $0.535B 13.56
Verve Therapeutics (VERV) United States $0.511B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.456B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Altimmune (ALT) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.420B 8.78
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 10.13
Organogenesis (ORGO) United States $0.365B 0.00
Aquestive Therapeutics (AQST) United States $0.355B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.68
MediWound (MDWD) Israel $0.234B 0.00
ProKidney (PROK) United States $0.230B 0.00
Esperion Therapeutics (ESPR) United States $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.181B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
OmniAb (OABI) United States $0.169B 0.00
Larimar Therapeutics (LRMR) United States $0.158B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Wellgistics Health (WGRX) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.090B 14.77
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Lyra Therapeutics (LYRA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00